Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort.

Gastaca M, Valdivieso A, Bustamante J, Fernández JR, Ruiz P, Ventoso A, Testillano M, Palomares I, Salvador P, Prieto M, Montejo M, Suárez MJ, de Urbina JO.

Liver Transpl. 2016 Oct;22(10):1391-400. doi: 10.1002/lt.24514.

2.

A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.

de la Torre MA, Buades-Mateu J, de la Rosa PA, Lué A, Bustamante FJ, Serrano MT, Testillano M, Lorente S, Arenas JI, Gil C, Iñarrairaegui M, Sangro B.

Liver Int. 2016 Aug;36(8):1206-12. doi: 10.1111/liv.13098. Epub 2016 Mar 23.

PMID:
26910784
3.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.

Agüero F, Forner A, Manzardo C, Valdivieso A, Blanes M, Barcena R, Rafecas A, Castells L, Abradelo M, Torre-Cisneros J, Gonzalez-Dieguez L, Salcedo M, Serrano T, Jimenez-Perez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators.

Hepatology. 2016 Feb;63(2):488-98. doi: 10.1002/hep.28321. Epub 2016 Jan 4.

PMID:
26516761
4.

Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study.

Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miró JM; FIPSE/NIH HIVTR/NEAT023 Investigators.

Am J Transplant. 2016 Feb;16(2):679-87. doi: 10.1111/ajt.13461. Epub 2015 Sep 28.

PMID:
26415077
5.

Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis.

Salmerón J, Vinaixa C, Berenguer R, Pascasio JM, Sánchez Ruano JJ, Serra MÁ, Gila A, Diago M, Romero-Gómez M, Navarro JM, Testillano M, Fernández C, Espinosa D, Carmona I, Pons JA, Jorquera F, Rodriguez FJ, Pérez R, Montero JL, Granados R, Fernández M, Martín AB, Muñoz de Rueda P, Quiles R; Alhambra Spanish Study Group.

World J Gastroenterol. 2015 Aug 14;21(30):9163-74. doi: 10.3748/wjg.v21.i30.9163.

6.

Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.

Bilbao I, Salcedo M, Gómez MA, Jimenez C, Castroagudín J, Fabregat J, Almohalla C, Herrero I, Cuervas-Mons V, Otero A, Rubín A, Miras M, Rodrigo J, Serrano T, Crespo G, De la Mata M, Bustamante J, Gonzalez-Dieguez ML, Moreno A, Narvaez I, Guilera M; EVEROLIVER study group.

Liver Transpl. 2015 Aug;21(8):1056-65. doi: 10.1002/lt.24172.

7.

Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities.

Buti M, Morillas RM, Pérez J, Prieto M, Solà R, Palau A, Diago M, Bonet L, Gallego A, García-Samaniego J, Testillano M, Rodríguez M, Castellano G, Gutiérrez ML, Delgado M, Mas A, Romero-Gómez M, Calleja JL, González-Guirado A, Arenas JI, García-Buey L, Andrade R, Gila A; ORIENTE-2 study group.

Eur J Gastroenterol Hepatol. 2015 Jan;27(1):46-54. doi: 10.1097/MEG.0000000000000195.

PMID:
25341057
8.

Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.

Castells L, Rimola A, Manzardo C, Valdivieso A, Montero JL, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, González-García J, Esteban-Mur JI, Miro JM; FIPSE LT-HIV Investigators.

J Hepatol. 2015 Jan;62(1):92-100. doi: 10.1016/j.jhep.2014.07.034. Epub 2014 Aug 13. Erratum in: J Hepatol. 2016 Mar;64(3):757.

PMID:
25127748
9.

Computerized physician order entry in the cardiac intensive care unit: effects on prescription errors and workflow conditions.

Armada ER, Villamañán E, López-de-Sá E, Rosillo S, Rey-Blas JR, Testillano ML, Alvarez-Sala R, López-Sendón J.

J Crit Care. 2014 Apr;29(2):188-93. doi: 10.1016/j.jcrc.2013.10.016. Epub 2013 Oct 29.

PMID:
24287174
10.

Biliary complications in orthotopic liver transplantation using choledochocholedochostomy with a T-tube.

Gastaca M, Matarranz A, Muñoz F, Valdivieso A, Aguinaga A, Testillano M, Bustamante J, Terreros I, Suarez MJ, Montejo M, Ortiz de Urbina J.

Transplant Proc. 2012 Jul-Aug;44(6):1554-6. doi: 10.1016/j.transproceed.2012.05.025.

PMID:
22841211
11.

Does the transjugular intrahepatic portosystemic influence the outcome of liver transplantation?

Valdivieso A, Ventoso A, Gastaca M, Bustamante J, Aguinaga A, Ruiz P, Gonzalez-Uriarte J, Martínez-Indart L, Testillano M, Fernández JR, Muñoz F, Montejo M, Matarranz A, Suárez MJ, Ortiz de Urbina J.

Transplant Proc. 2012 Jul-Aug;44(6):1505-7. doi: 10.1016/j.transproceed.2012.05.070. No abstract available.

PMID:
22841197
12.

Liver retransplantation in HIV-infected patients: a prospective cohort study.

Gastaca M, Aguero F, Rimola A, Montejo M, Miralles P, Lozano R, Castells L, Abradelo M, Mata Mde L, San Juan Rodríguez F, Cordero E, Campo Sd, Manzardo C, de Urbina JO, Pérez I, Rosa Gde L, Miro JM; FIPSE OLT-HIV investigators.

Am J Transplant. 2012 Sep;12(9):2465-76. doi: 10.1111/j.1600-6143.2012.04142.x. Epub 2012 Jun 15.

13.

Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.

Miro JM, Montejo M, Castells L, Rafecas A, Moreno S, Agüero F, Abradelo M, Miralles P, Torre-Cisneros J, Pedreira JD, Cordero E, de la Rosa G, Moyano B, Moreno A, Perez I, Rimola A; Spanish OLT in HIV-Infected Patients Working Group investigators.

Am J Transplant. 2012 Jul;12(7):1866-76. doi: 10.1111/j.1600-6143.2012.04028.x. Epub 2012 Apr 4.

14.

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patients.

Buti M, Morillas RM, Prieto M, Diago M, Pérez J, Solà R, Bonet L, Palau A, Testillano M, García-Samaniego J, Rodríguez M; ORIENTE Study Group.

Eur J Gastroenterol Hepatol. 2012 May;24(5):535-42. doi: 10.1097/MEG.0b013e3283511287. Erratum in: Eur J Gastroenterol Hepatol. 2012 Aug;24(8):999.

PMID:
22382708
15.

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.

Gomez-Martin C, Bustamante J, Castroagudin JF, Salcedo M, Garralda E, Testillano M, Herrero I, Matilla A, Sangro B.

Liver Transpl. 2012 Jan;18(1):45-52. doi: 10.1002/lt.22434.

16.

Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.

Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, Len O, Rafecas A, Martín-Davila P, Torre-Cisneros J, Salcedo M, Cordero E, Lozano R, Pérez I, Rimola A, Miró JM; OLT-HIV FIPSE Cohort Investigators.

Liver Transpl. 2012 Jan;18(1):70-81. doi: 10.1002/lt.22431.

17.

Advagraf de novo in liver transplantation: a single-center experience.

Ortiz de Urbina J, Valdivieso A, Matarranz A, Gastaca M, Fernandez JR, Bustamante J, Gonzalez J, Ventoso A, Testillano M, Ruiz P, Suarez M.

Transplant Proc. 2011 Apr;43(3):724-5. doi: 10.1016/j.transproceed.2011.01.089.

PMID:
21486583
18.

Management of hepatocellular carcinoma recurrence after liver transplantation.

Valdivieso A, Bustamante J, Gastaca M, Uriarte JG, Ventoso A, Ruiz P, Fernandez JR, Pijoan I, Testillano M, Suarez MJ, Montejo M, Ortiz de Urbina J.

Transplant Proc. 2010 Mar;42(2):660-2. doi: 10.1016/j.transproceed.2010.02.014.

PMID:
20304217
19.

Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus D+/R-) liver transplant recipients: a single-center experience.

Montejo M, Montejo E, Gastaca M, Valdivieso A, Fernandez JR, Testillano M, Gonzalez J, Bustamante J, Ruiz P, Suarez MJ, Ventoso A, Rubio MC, de Urbina JO.

Transplant Proc. 2009 Jul-Aug;41(6):2189-91. doi: 10.1016/j.transproceed.2009.06.005.

PMID:
19715869
20.

Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.

Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.

Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030.

PMID:
19376421
Items per page

Supplemental Content

Loading ...
Write to the Help Desk